about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
6.32
0.61
(10.68%)
8.1M
XNAS Volume
High vol.+gain this week
XNAS 05 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Replimune Group Inc is on 08 Aug 2025 for the purpose of Replimune Group Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Replimune Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..